| 1 |
33961870 | Nasal-associated lymphoid tissue is the major induction site for nephritogenic IgA in murine IgA nephropathy. | 2021 Aug |
2 |
| 2 |
34128045 | Innate immunity stimulation via CpG oligodeoxynucleotides ameliorates Alzheimer's disease pathology in aged squirrel monkeys. | 2021 Aug 17 |
1 |
| 3 |
34555477 | Co-assembled nanocomplexes of peptide neoantigen Adpgk and Toll-like receptor 9 agonist CpG ODN for efficient colorectal cancer immunotherapy. | 2021 Oct 25 |
4 |
| 4 |
34678647 | Systemic toll-like receptor 9 agonist CpG oligodeoxynucleotides exacerbates aminoglycoside ototoxicity. | 2021 Nov |
1 |
| 5 |
32327959 | Role of Kupffer cells in liver injury induced by CpG oligodeoxynucleotide and flucloxacillin in mice. | 2020 |
2 |
| 6 |
32585230 | Co-delivery of antigen and dual adjuvants by aluminum hydroxide nanoparticles for enhanced immune responses. | 2020 Oct 10 |
2 |
| 7 |
30508414 | Evidence of an anti-inflammatory toll-like receptor 9 (TLR 9) pathway in adipocytes. | 2019 Feb 1 |
2 |
| 8 |
30993380 | A toll-like receptor 9 agonist sensitizes mice to mitochondrial dysfunction-induced hepatic apoptosis via the Fas/FasL pathway. | 2019 Jun |
1 |
| 9 |
31301576 | Cargo-less nanoparticles program innate immune cell responses to toll-like receptor activation. | 2019 Oct |
1 |
| 10 |
27157410 | The novel TLR9 antagonist COV08-0064 protects from ischemia/reperfusion injury in non-steatotic and steatotic mice livers. | 2016 Jul 15 |
1 |
| 11 |
26082836 | Immune modulating effects of cyclophosphamide and treatment with tumor lysate/CpG synergize to eliminate murine neuroblastoma. | 2015 |
1 |
| 12 |
24720881 | The effect of combined IL10 siRNA and CpG ODN as pathogen-mimicking microparticles on Th1/Th2 cytokine balance in dendritic cells and protective immunity against B cell lymphoma. | 2014 Jul |
2 |
| 13 |
24977403 | Phagocytosis of bafilomycin A1-treated apoptotic neuroblastoma cells by bone marrow-derived dendritic cells initiates a CD8α+ lymphocyte response to neuroblastoma. | 2014 Jul |
1 |
| 14 |
22917564 | CpG-ODN, the TLR9 agonist, attenuates myocardial ischemia/reperfusion injury: involving activation of PI3K/Akt signaling. | 2013 Jan |
1 |
| 15 |
23359590 | The Toll-like receptor 9 ligand, CpG oligodeoxynucleotide, attenuates cardiac dysfunction in polymicrobial sepsis, involving activation of both phosphoinositide 3 kinase/Akt and extracellular-signal-related kinase signaling. | 2013 May 1 |
2 |
| 16 |
23443666 | Interferon-γ and granulocyte/monocyte colony-stimulating factor production by natural killer cells involves different signaling pathways and the adaptor stimulator of interferon genes (STING). | 2013 Apr 12 |
1 |
| 17 |
23475790 | CpG-oligodeoxynucleotide-induced TLR9 activation regulates macrophage TREM-1 expression and shedding. | 2013 Dec |
1 |
| 18 |
20725994 | CpG-ODN increases the release of VEGF in a mouse model of lung carcinoma. | 2011 Jun 15 |
1 |
| 19 |
21278302 | B cells contribute to the antitumor activity of CpG-oligodeoxynucleotide in a mouse model of metastatic lung carcinoma. | 2011 May 15 |
1 |
| 20 |
21497117 | Granulin is a soluble cofactor for toll-like receptor 9 signaling. | 2011 Apr 22 |
1 |
| 21 |
21788345 | Immune adjuvant efficacy of CpG oligonucleotide in cancer treatment is founded specifically upon TLR9 function in plasmacytoid dendritic cells. | 2011 Oct 15 |
1 |
| 22 |
22174879 | Activation of the alternative NFκB pathway improves disease symptoms in a model of Sjogren's syndrome. | 2011 |
1 |
| 23 |
21116790 | Biodegradable nanoparticles containing TLR3 or TLR9 agonists together with antigen enhance MHC-restricted presentation of the antigen. | 2010 Nov |
1 |
| 24 |
19200852 | Activation of toll-like receptor signaling pathway for protection against influenza virus infection. | 2009 May 26 |
1 |
| 25 |
17599410 | TLR9 cooperates with TLR4 to increase IL-12 release by murine dendritic cells. | 2008 Jan |
1 |
| 26 |
18981089 | TLR ligands in the local treatment of established intracerebral murine gliomas. | 2008 Nov 15 |
2 |
| 27 |
17475835 | Involvement of heat shock protein (Hsp)90 beta but not Hsp90 alpha in antiapoptotic effect of CpG-B oligodeoxynucleotide. | 2007 May 15 |
1 |
| 28 |
17785797 | Negative regulation of TLR-signaling pathways by activating transcription factor-3. | 2007 Sep 15 |
1 |
| 29 |
16402377 | Interleukin (IL)-12 mediates the anti-osteoclastogenic activity of CpG-oligodeoxynucleotides. | 2006 Apr |
1 |
| 30 |
16458386 | Toll-like receptor 9 (TLR9) is present in murine liver sinusoidal endothelial cells (LSECs) and mediates the effect of CpG-oligonucleotides. | 2006 May |
2 |
| 31 |
17046822 | CpG-B oligodeoxynucleotide promotes cell survival via up-regulation of Hsp70 to increase Bcl-xL and to decrease apoptosis-inducing factor translocation. | 2006 Dec 15 |
1 |
| 32 |
16059640 | Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis. | 2005 Sep |
3 |
| 33 |
14988381 | Lipopolysaccharide-induced osteoclastogenesis in Src homology 2-domain phosphatase-1-deficient viable motheaten mice. | 2004 Jun |
1 |